1-(naphthalen-2-yl)propan-1-ol | 132154-59-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(naphthalen-2-yl)propan-1-ol
• 英文别名: 1-(2-naphthyl)-1-propanol；1-(2-naphthyl)propanol；1-naphthalen-2-ylpropan-1-ol
• CAS: 132154-59-7
• 化学式: C₁₃H₁₄O
• 分子量: 186.254
• InChiKey: GYGXCXXVEPTSQL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2906299090

反应信息

• 作为反应物：
  描述：

  1-(naphthalen-2-yl)propan-1-ol 在 palladium diacetate 、 三丁基膦 、 对甲苯磺酸 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 、 叔丁醇 、 苯 为溶剂， 反应 1.67h， 生成 1-萘-2-基丙烷-2-酮
  参考文献：
  名称：

  Palladium-Catalyzed Isomerization of Aryl-Substituted Epoxides:  A Selective Synthesis of Substituted Benzylic Aldehydes and Ketones

  摘要：

  Aryl-substituted epoxides bearing multiple methyl substituents on the epoxide ring isomerize in the presence of 5 mol % Pd(OAc)(2)PR3 (R = n-Bu, Ph) to form the corresponding benzylic aldehyde or ketone, with complete regioselectivity for the carbonyl compound formed via cleavage of the benzylic C-O bond. No allylic alcohols or products arising from alkyl migration are observed. Rapid reaction rates and nearly quantitative yields are obtained, even with highly sterically hindered epoxides, using tri-n-butylphosphine as ligand and tert-butyl alcohol as solvent. 2-Aryl-substituted epoxides with two methyl substituents on C3 are completely unreactive, consistent with an oxidative addition/beta-hydride elimination mechanism. Catalyst variation studies show that both Pd(OAc)(2) and PR3 are essential for optimal activity and that palladium catalysts formed in this manner are superior to other Pd(O) catalysts (e.g., Pd(PPh3)(4)). The reactivity of catalytic Pd(OAc)(2)/PR3 toward multiply-substituted epoxides is compared to traditional Lewis acid catalysts; the former is found to be much more selective for isomerization without skeletal rearrangement. A mechanistic rationale involving turnover-limiting S(N)2-like attack of Pd(O) at the benzylic carbon is proposed.

  DOI：

  10.1021/jo970743b
• 作为产物：
  描述：

  1-(萘-2-基)丙-2-烯-1-醇 在 C₁₉H₃₃ClIrN₃O 、 sodium isopropylate 作用下， 以 异丙醇 为溶剂， 反应 1.0h， 生成 1-(naphthalen-2-yl)propan-1-ol
  参考文献：
  名称：

  三唑基铱配合物用于C═O，C═N和C═C键的高效和多功能转移加氢以及无受体醇氧化

  摘要：

  据报道，一组铱（I）和铱（III）配合物带有三唑基亚烷基配体，这些配体包含苯并恶唑，噻唑和甲基醚侧基作为潜在的螯合供体位点。这些基团的键合模式通过NMR光谱和X射线结构分析来鉴定。在转移氢化和无受体醇氧化中，将该配合物评价为催化剂前体。高价铱（III）配合物被确定为氧化醇脱氢最活跃的前体，而具有甲基醚官能团的低价铱（I）配合物在还原转移氢化中最活跃。这种催化剂的前体用途广泛，可以有效地氢化酮，醛，亚胺，烯丙基醇，尤其是非极化烯烃，转移加氢反应非常困难的基质。周转频率高达260小时记录了–1的烯烃氢化反应，而氢转移到酮和醛中的最大周转频率大于2000 h –1。结合同位素标记实验，动力学同位素效应测量和Hammett参数相关性进行的机械研究表明，限制转移的步骤是转移氢化过程中金属从氢化物向基质的氢化物转移，而在醇脱氢中，限制步骤是基质协调到金属中心。

  DOI：

  10.1021/acs.inorgchem.7b01707

文献信息

• Chiral 2-(2-hydroxyaryl)alcohols (HAROLs) with a 1,4-diol scaffold as a new family of ligands and organocatalysts
  作者：Ömer Dilek、Mustafa A. Tezeren、Tahir Tilki、Erkan Ertürk

  DOI：10.1016/j.tet.2017.11.054

  日期：2018.1

  Efficient and modular syntheses of chiral 2-(2-hydroxyaryl)alcohols (HAROLs), novel 1,4-diols carrying one phenolic and one alcohol hydroxyl group, have been developed which led to generation of a small library of structurally diverse HAROLs in enantiomerically pure form. Of the different HAROLs examined, a HAROL based on the indan backbone exhibited the highest activity and enantioselectivity in the

  高效和模块化的手性2-（2-羟基芳基）醇（HAROLs）的合成，带有一个酚和一个醇羟基的新型1,4-二醇已被开发出来，这导致在对映异构体中生成结构多样的HAROLS小文库纯形式。在考察的不同HAROL中，基于茚满骨架的HAROL在Ti（O i Pr）4（y高达97％， 88％ee）并在三田膦的促进下在Morita-Baylis-Hillman反应中作为氢键供体有机催化剂发挥作用。
• B(C₆F₅)₃-Catalyzed Hydrodesulfurization Using Hydrosilanes – Metal-Free Reduction of Sulfides
  作者：Kodai Saito、Kazumi Kondo、Takahiko Akiyama

  DOI：10.1021/acs.orglett.5b01651

  日期：2015.7.2

  B(C6F5)3-catalyzed hydrodesulfurization of carbon–sulfur bonds was achieved using triethylsilane as the reducing agent. The corresponding products were obtained in good yields under mild reaction conditions. This protocol could be applied to the reduction of sulfides, including benzyl and alkyl sulfides and dithianes, with high chemoselectivities.

  使用三乙基硅烷作为还原剂，实现了B（C 6 F 5）3催化的碳硫键加氢脱硫。在温和的反应条件下以高收率获得了相应的产物。该方案可用于具有高化学选择性的硫化物的还原，包括苄基和烷基硫化物以及二噻烷。
• ENZYME-CATALYZED ENANTIOSELECTIVE AZIRIDINATION OF OLEFINS
  申请人：California Institute of Technology

  公开号：US20160222423A1

  公开（公告）日：2016-08-04

  The present invention provides methods for catalyzing the conversion of an olefin to a compound containing one or more aziridine functional groups using heme enzymes. In certain aspects, the present invention provides a reaction mixture for producing an aziridination product, the reaction mixture comprising of an olefinic substrate, a nitrene precursor, and a heme enzyme. In other certain aspects, the present invention provides a method for producing an aziridination product comprising providing an olefinic substrate, a nitrene precursor, and a heme enzyme; and admixing the components in a reaction for a time sufficient to produce an aziridine product. In other aspects, the present invention provides heme enzymes including variants and fragments thereof that are capable of carrying out in vivo and in vitro olefin aziridination reactions. Expression vectors and host cells expressing the heme enzymes are also provided by the present invention.

  本发明提供了利用血红素酶催化烯烃转化为含有一个或多个氮杂环丙烷官能团的化合物的方法。在某些方面，本发明提供了用于生产氮杂环丙烷产物的反应混合物，该反应混合物包括烯烃底物、氮烯前体和血红素酶。在其他某些方面，本发明提供了一种生产氮杂环丙烷产物的方法，包括提供烯烃底物、氮烯前体和血红素酶；并将这些组分混合在反应中，以产生氮杂环丙烷产物所需的时间。在其他方面，本发明提供了包括能够在体内和体外进行烯烃氮杂环丙烷化反应的血红素酶及其变体和片段。本发明还提供了表达载体和表达血红素酶的宿主细胞。
• CAMPHOR-DERIVED COMPOUNDS, METHOD FOR MANUFACTURING THE SAME, AND APPLICATION THEREOF
  申请人：UANG Biing-Jiun

  公开号：US20120077976A1

  公开（公告）日：2012-03-29

  Camphor-derived compounds are disclosed, which are represented as the following formula (I): wherein R 1 , R 2 , R 3 , and R 4 each are defined as described in the specification. In addition, a method for manufacturing the camphor-derived compounds and application thereof are disclosed.

  揿脑素衍生化合物的结构如下式（I）所示： 其中R1、R2、R3和R4分别如规范中所述定义。此外，还公开了一种制造揿脑素衍生化合物和应用它们的方法。
• [EN] SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE SUBSTITUÉS
  申请人：BAYER AG

  公开号：WO2019219517A1

  公开（公告）日：2019-11-21

  The invention relates to substituted dihydropyrazolo pyrazine carboxamide derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and diabetes, and also urogenital and ophthalmic disorders.

  这项发明涉及替代二氢吡唑吡嗪羧酰胺衍生物，以及它们的制备方法，还涉及它们用于制备治疗和/或预防疾病的药物，特别是心血管疾病，优选为血栓性或血栓栓塞性疾病，糖尿病，以及泌尿生殖和眼科疾病。